Biotherapharma_logo.jpg
Biothera Pharmaceuticals Presents Data Broadening Imprime PGG Mechanism of Action
November 13, 2017 09:30 ET | Biothera Pharmaceuticals, Inc.
Reduces expression of IDO, a potent suppressor of an anti-cancer T cell response Supplementation with IVIG boosts biomarker levels, restoring Imprime-driven pharmacodynamic responses EAGAN, Minn.,...